FIRST TRUST ADVISORS LP – Regeneron Pharmaceuticals, Inc. Transaction History
FIRST TRUST ADVISORS LP portfolio value:
$312.25M
portfolio value
FIRST TRUST ADVISORS LP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +13.73% | 54.71K shares | 76.64M | $688.87 | 453.28K |
| Q2 2022 | share | Increase | +130.55% | 225.69K shares | 114.86M | $591.13 | 398.57K |
| Q1 2022 | share | Decrease | -15.13% | -30.81K shares | -7.89M | $698.42 | 172.87K |
| Q4 2021 | share | Increase | +3.02% | 5.96K shares | 8.97M | $642.51 | 203.68K |
| Q3 2021 | share | Increase | +14.79% | 25.46K shares | 23.44M | $605.18 | 197.71K |
| Q2 2021 | share | Decrease | -1.04% | -1.80K shares | 13.85M | $558.54 | 172.25K |
| Q1 2021 | share | Increase | +7.50% | 12.13K shares | 4.12M | $473.14 | 174.05K |
| Q4 2020 | share | Decrease | -55.53% | -202.22K shares | -125.61M | $483.11 | 161.92K |
| Q3 2020 | share | Increase | +1.42% | 5.08K shares | -20.08M | $559.78 | 364.14K |
| Q2 2020 | share | Increase | +43.47% | 108.79K shares | 101.72M | $623.65 | 359.06K |
| Q1 2020 | share | Decrease | -18.36% | -56.28K shares | 7.09M | $488.29 | 250.26K |
| Q4 2019 | share | Increase | +3.48% | 10.32K shares | 32.93M | $375.48 | 306.55K |
| Q3 2019 | share | Decrease | -14.62% | -50.72K shares | -26.42M | $277.4 | 296.23K |
| Q2 2019 | share | Decrease | -3.77% | -13.60K shares | -39.45M | $313 | 346.96K |
| Q1 2019 | share | Increase | +23.88% | 69.49K shares | 39.34M | $410.62 | 360.56K |
| Q4 2018 | share | Increase | +0.90% | 2.58K shares | -7.84M | $373.5 | 291.06K |
| Q3 2018 | share | Increase | +53.46% | 100.49K shares | 51.70M | $404.04 | 288.48K |
| Q2 2018 | share | Increase | +26.93% | 39.87K shares | 13.85M | $344.99 | 187.98K |
| Q1 2018 | share | Increase | +21.88% | 26.58K shares | 5.31M | $344.36 | 148.10K |
| Q4 2017 | share | Decrease | -18.61% | -27.78K shares | -21.07M | $375.96 | 121.52K |
| Q3 2017 | share | Increase | +35.22% | 38.88K shares | 12.52M | $447.12 | 149.31K |
| Q2 2017 | share | Increase | +17.74% | 16.63K shares | 17.89M | $491.14 | 110.42K |
| Q1 2017 | share | Decrease | -24.28% | -30.07K shares | -9.12M | $387.51 | 93.78K |
| Q4 2016 | share | Increase | +43.70% | 37.66K shares | 10.81M | $367.09 | 123.85K |
| Q3 2016 | share | Decrease | -0.82% | -710 shares | 4.30M | $402.02 | 86.19K |
| Q2 2016 | share | Decrease | -46.18% | -74.57K shares | -27.85M | $349.23 | 86.9K |
| Q1 2016 | share | Decrease | -55.44% | -200.94K shares | -138.54M | $360.44 | 161.47K |